[18F]FES PET/CT in PAH
NCT02899533 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2021-05-18
Summary
In this study positron emission tomography (PET/CT) imaging will be used to evaluate evaluation of estrogen receptor heterogeneity and functionality in Pulmonary Arterial Hypertension (PAH) using the investigational radiotracer \[18F\]fluoroestradiol (FES).
Conditions
Interventions
- DRUG
-
[18F] FES
\[18F\] FES PET/CT scan, imaging tracer
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
David Mankoff, MD, PhD · University of Pennsylvania
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2021-04-06
- Completion
- 2021-04-06
Countries
- United States
Study Locations
More Related Trials
-
Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation
NCT04488094 ·Status: COMPLETED ·Phase: PHASE2
-
FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
NCT02398773 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
FES-PET for Patients Treated on NCI Protocol 8762
NCT01714128 ·Status: WITHDRAWN ·Phase: NA
-
PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient
NCT03295695 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation
NCT04901884 ·Status: RECRUITING ·Phase: NA
-
Cardiac Perfusion and Metabolism With [11C] Acetate PET/CT is Associated With Hematopoietic System Activation in Acute Decompensated Heart Failure: An Imaging Sub-study
NCT03924102 ·Status: WITHDRAWN ·Phase: PHASE1
-
FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET
NCT03726931 ·Status: COMPLETED ·Phase: NA
-
18F-FES PET/CT in Imaging Patients With Desmoid Tumors
NCT02374931 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
PET Assessment of Acute Lung Transplant Rejection
NCT02204202 ·Status: TERMINATED
-
Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status
NCT01916122 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents
NCT02325349 ·Status: TERMINATED ·Phase: PHASE2
-
[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer
NCT02297386 ·Status: COMPLETED ·Phase: PHASE1
-
Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors
NCT04510311 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging
NCT00499382 ·Status: TERMINATED
-
18F-fluoroestradiol (FES) PET/CT for Breast Cancer
NCT04883814 ·Status: UNKNOWN ·Phase: PHASE2
-
F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer
NCT00602043 ·Status: COMPLETED ·Phase: PHASE2
-
[18F]FES PET/.CT in Uterine Cancer
NCT05916196 ·Status: RECRUITING ·Phase: PHASE2
-
Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET
NCT07285993 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET
NCT03065712 ·Status: WITHDRAWN ·Phase: PHASE2
-
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
NCT01931709 ·Status: TERMINATED ·Phase: NA
-
FAPI-PET for Tumor Detection
NCT04571086 ·Status: RECRUITING
-
Tracer Targeting FAP PET Imaging in Patients
NCT05691894 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
NCT03824535 ·Status: COMPLETED ·Phase: PHASE2
-
[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer
NCT02284919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Advanced Imaging for Pulmonary Fibrosis
NCT06532071 ·Status: RECRUITING ·Phase: PHASE2